Q04 Prescription of long-term drug therapy for asthma Number of individuals aged 5-40 years with a diagnosis of mild, moderate, or severe persistent asthma and prescribed either the preferred long‐term control medication (inhaled corticosteroid) or an acceptable alternative treatment Number of individuals aged 5-40 years with a diagnosis of mild, moderate, or severe persistent asthma DEC† ROR: 0.81 [0.74-0.89] DEC† ROR: 0.56 [0.41-0.76] DEC† ROR: 0.60 [0.50-0.71] NA NA NA Q05 Persistence with ACE inhibitor or ARB therapy for diabetes Number of individuals aged 18 and older with a diagnosis of diabetes and persistent with ACE inhibitor or ARB therapy Number of individuals aged 18 years and older with a diagnosis of diabetes INC ROR: 1.12 [0.94-1.33] DEC ROR: 0.95 [0.82-1.11] DEC† ROR: 0.73 [0.61-0.86] NA NA NA Q06 Well-care visits for children Number of children 3–6 years old with one or more well–child visits to any PCP Number of children aged 3-6 years DEC Δ: -0.02 [SE: 0.02] NA DEC* Δ: -0.05 [SE: 0.02] NC Δ: 0.00 [SE: 0.02] INC Δ: 0.02 [SE: 0.03] INC Δ: 0.01 [SE: 0.02]
Q07 Well-care visits for adolescents and young adults Number of individuals aged 12–21 years with one or more PCP or OB/GYN visits Number of individuals aged 12–21 years DEC Δ: -0.03 [SE: 0.02] DEC† Δ: -0.08 [SE: 0.03] DEC† Δ: -0.09 [SE: 0.03] INC* Δ: 0.03 [SE: 0.01] INC Δ: 0.02 [SE: 0.01] INC* Δ: 0.05 [SE: 0.02] Q08 Asthma admissions (<40 years) Number of individuals less than 40 years of age diagnosed with asthma and recording one or more inpatient admissions Number of individuals diagnosed with asthma and younger than 40 years of age INC ROR: 1.28 [0.95-1.73] DEC ROR: 0.78 [0.53-1.14] DEC* ROR: 0.49 [0.30-0.82] NA NA NA Q09 Asthma admissions (≥40 years) Number of individuals 40 years or older diagnosed with asthma or COPD and recording one or more inpatient admissions Number of individuals 40 years or older and diagnosed with asthma or COPD INC ROR: 1.74 [0.84-3.62] INC ROR: 1.28 [0.63-2.56] INC ROR: 1.01 [0.73-1.40] NA NA NA Q10 Hypertension admissions Number of individuals diagnosed with hypertension and recording one or more Number of individuals diagnosed with hypertension INC* ROR: 1.75 [1.14-2.69] NA NA NA NA NA diagnosis- related
Q15 Prescription for ACE inhibitor or ARB therapy for LVSD or HF Number of adults diagnosed with LVSD or HF and prescribed ACE inhibitor or ARB therapy Number of adults diagnosed with LVSD or HF DEC* ROR: 0.57 [0.37-0.87] DEC ROR: 0.57 [0.30-1.07] DEC ROR: 0.86 [0.29-2.48] NA NA NA Q16 Persistence on ACE inhibitor or ARB therapy for LVSD or HF Number of adults diagnosed with LVSD or HF and persistent with prescribed ACE inhibitor or ARB therapy Number of adults diagnosed with LVSD or HF INC ROR: 1.12 [0.85-1.47] DEC ROR: 0.89 [0.64-1.24] DEC ROR: 0.77 [0.39-1.50] NA NA NA HEALTH SERVICES UTILIZATION MEASURES U01 Proportion with ED visit Number of patients with one or more ED visits Total number of patients INC ROR: 1.04 [0.94-1.13] DEC ROR: 0.92 [0.85-1.00] DEC ROR: 0.91 [0.84-0.99] DEC ROR: 0.99 [0.96-1.03] INC ROR: 1.07 [1.00-1.15] INC ROR: 1.03 [0.94-1.13] U02 Proportion of asthma, CHF, or diabetes patients with ED visit Number of patients diagnosed with asthma, CHF, or diabetes and recording a ED visit Number of patients diagnosed with any of these conditions DEC* ROR: 0.89 [0.82-0.96] DEC ROR: 0.86 [0.72-1.04] DEC* ROR: 0.81 [0.70-0.94] INC ROR: 1.17 [0.90-1.50] DEC ROR: 0.98 [0.70-1.35] INC* ROR: 1.51 [1.09-2.10]
U13 Total hospice days Total number of calendar days spent in hospice among patients with a hospice stay Number of patients with at least one hospice stay NA NA NA INC Δ: 15.46 [SE: 33.46] INC Δ: 11.88 [SE: 41.13] NA U14 Mean prescriptions Total number of pharmaceutical prescriptions filled by patients Number of patients with at least one prescription DEC* Δ: -0.39 [SE: 0.18] DEC Δ: -0.30 [SE: 0.29] DEC Δ: -0.32 [SE: 0.27] NA NA NA U15 Proportion of asthma patients with ED Number of patients diagnosed with asthma and recording a ED visit Number of patients diagnosed with asthma DEC* ROR: 0.90 [0.83-0.97] DEC ROR: 0.85 [0.70-1.02] DEC† ROR: 0.77 [0.67-0.88] INC ROR: 1.19 [0.92-1.53] INC ROR: 1.02 [0.72-1.46] INC* ROR: 1.55 [1.12-2.14] U16 Proportion of CHF patients with ED visit Number of patients diagnosed with CHF and recording a ED visit Number of patients diagnosed with CHF DEC ROR: 0.83 [0.49-1.40] INC ROR: 1.10 [0.43-2.81] INC ROR: 2.66 [0.78-9.07] INC ROR: 1.57 [0.34-7.36] DEC ROR: 0.87 [0.18-4.24] INC ROR: 2.20 [0.84-5.71] U17 Proportion of diabetic patients with ED visit Number of patients diagnosed with diabetes and recording a ED visit Number of patients diagnosed with diabetes DEC ROR: 0.52 [0.14-1.94] INC ROR: 1.09 [0.53-2.25] INC ROR: 2.47 [0.53-11.60] NA DEC ROR: 0.19 [0.03-1.10] DEC ROR: 0.38 [0.07-2.01]
U18 Proportion of asthma patients with inpatient visit Number of patients diagnosed with asthma and recording a inpatient visit Number of patients diagnosed with asthma INC ROR: 1.14 [0.95-1.37] DEC ROR: 0.93 [0.75-1.15] DEC* ROR: 0.56 [0.36-0.87] NC ROR: 1.00 [0.63-1.59] DEC ROR: 0.75 [0.47-1.20] INC ROR: 1.02 [0.54-1.92] U19 Proportion of CHF patients with inpatient visit Number of patients diagnosed with CHF and recording a inpatient visit Number of patients diagnosed with CHF DEC ROR: 0.58 [0.34-0.99] DEC ROR: 0.68 [0.37-1.24] DEC ROR: 0.87 [0.59-1.29] INC ROR: 1.07 [0.52-2.19] DEC ROR: 0.75 [0.38-1.49] DEC ROR: 0.75 [0.33-1.70] U20 Proportion of diabetic patients with inpatient visit Number of patients diagnosed with diabetes and recording a inpatient visit Number of patients diagnosed with diabetes INC ROR: 1.91 [0.84-4.32] INC† ROR: 2.76 [1.69-4.53] INC ROR: 1.75 [0.80-3.85] DEC ROR: 0.51 [0.18-1.42] DEC ROR: 0.74 [0.36-1.53] INC ROR: 1.01 [0.36-2.83] HEALTH EXPENDITURE / COST MEASURES C01 Mean inpatient expenditure for hospitalized patients Total inpatient payments among patients Number of patients with inpatient payments DEC* Δ: -$6,242 [SE: $2,577] DEC* Δ: -$5,873 [SE: $2,315] DEC* Δ: -$6,447 [SE: $2,423] INC Δ: $6 [SE: $1,061] DEC Δ: -$525 [SE: $973] INC Δ: $1,040 [SE: $931]
C07 Mean hospice payments among patients with hospice care hospice expenditure among patients Number of patients receiving hospice care NA NA NA INC Δ: $3,014 [SE: $5,425] INC Δ: $4,425 [SE: $5,845] INC Δ: $3,011 [SE: $2,139] C08 Mean radiology payments patients with radiology encounters Total radiology expenditure among patients Number of patients receiving radiology services INC Δ: $15 [SE: $9] INC Δ: $65 [SE: $58] INC Δ: $58 [SE: $41] DEC Δ: -$13 [SE: $18] INC Δ: $21 [SE: $19] INC Δ: $9 [SE: $20] C09 Mean laboratory payments among patients with laboratory service Total laboratory services expenditure among patients Number of patients receiving laboratory services INC Δ: $11 [SE: $10] INC Δ: $207 [SE: $311] INC Δ: $105 [SE: $189] DEC Δ: -$14 [SE: $10] DEC Δ: -$22 [SE: $13] DEC Δ: -$13 [SE: $13] C10 Mean prescription costs among patients with a prescription fill Total pharmaceutical payments among patients Number of patients with at least one prescription fill INC Δ: $216 [SE: $394] INC Δ: $360 [SE: $414] INC Δ: $311 [SE: $436] NA NA NA C11 Mean payments for other services Total expenditure among patients for services not covered in categories above Total number of patients DEC† Δ: -$353 [SE: $88] INC Δ: $70 [SE: $165] INC Δ: $119 [SE: $193] DEC* Δ: -$56 [SE: $24] DEC Δ: -$5 [SE: $26] DEC Δ: -$33 [SE: $28]